Influx Healthtech is a contract manufacturer that turns other companies’ product ideas into finished pills, powders, creams and drinks - it does not sell anything under its own brand. Founded in 2020 by a pharmacist who had already spent 17 years in the industry, the business was built on a single recurring logic: own the entire journey from formulation to regulatory filing, so that a client can hand over a concept and receive a shelf-ready product. That same end-to-end approach now repeats across nutraceuticals, cosmetics, pet care and beverages, with the company describing itself as a “365 CDMO” - a partner that handles development, manufacturing and compliance under one roof.
Business segments
One core engine that supplies roughly nine-tenths of revenue, surrounded by three smaller CDMO lines and a beverage start-up - all sharing the same Palghar factory floors, certifications and “idea-to-shelf” model.
1. Nutraceutical contract manufacturing: the factory behind the supplement aisle
It makes every common supplement format - tablets, capsules, gummies, powders, liquids - for over 700 brand owners who never touch a production line.
- Widest menu in the category - the company offers 3,428 products across formats that span tablets, capsules, soft gels, liquid orals, oral powders, effervescent tablets, gummies, protein bars, snack bars and single-dose sachets, and the MD feels they have the widest range of nutraceutical cosmetic to offer to clients.
- Formulation is the front door - an in-house team of eight formulation scientists designs recipes, estimates costs and refines prototypes before a single commercial batch is run, so clients arrive with an idea and leave with a finished, regulator-ready product.
- Capacity added ahead of demand - daily nutraceutical capacity rose from 10,000 kg to 17,000 kg in FY26, and a major expansion in July 2025 doubled liquid lines to 48,000 bottles per shift and lifted sachet output to 98,000 per shift, releasing roughly 40 percentage points of headroom.
- A sixfold capsule leap - a new high-speed capsule machine expected to be operational within the current month took hourly capsule capacity from 23,000 to 145,000, because existing lines were already running at 90% utilisation.
- Proprietary formats as a moat - its Quick Snap™ single-dose delivery system and MMTC (Multi-Mini Tablet in Capsule) technology place it among only a handful of Indian CDMOs that can offer these formats, which helps win business from D2C wellness brands and clinical-nutrition startups.
2. Cosmetics and ayurveda: the same factory, different jars
It applies the identical CDMO playbook to skincare creams, herbal oils and personal-care formats, contributing about 9% of revenue between the two lines.
- Two labels, one production floor - cosmetics (roughly 5% of revenue) covers creams, gels, soaps and advanced items like waterless sunscreen, while ayurvedic products (roughly 4%) spans herbal tablets and traditional oils, with the combined Cosmetics & Ayurvedic segment having 3,150 kg of daily installed capacity.
- Innovation cadence matches nutraceuticals - the company has rolled out dry shampoos, face masks, ayurvedic gummies and is now developing colour-changing sunscreens, using the same F&D team and Quick Snap™ single-dose technology that serve the supplement business.
- Certification umbrella lowers the entry barrier - the Palghar facilities that hold FSSC 22000, GMP, HACCP, Halal, ISO 22000 and US FDA registration cover cosmetics and ayurveda too, so a brand launching a herbal cream gets the same quality assurance as a multinational ordering protein powder.
3. Pet care and veterinary: a small line with a big extrusion bet
It currently produces about 16-18 tonnes of pet food and animal supplements a month, but an eightfold capacity upgrade is on order.
- Products span companion and farm animals - the range includes dog and cat food, nutrition toppers, mineral mixtures and poultry additives, with pet floor cleanser and nutritional oral gel added in the last two years.
- A dedicated facility is funded - ₹6 crore of IPO proceeds are earmarked for a standalone veterinary-food plant on a 1,350 m² site, and the company has flagged plans to house pet nutrition in a separate subsidiary.
4. Ready-to-drink wellness beverages: the subsidiary that has not yet bottled
A wholly owned subsidiary incorporated in February 2026 will make functional drinks, protein shakes and carbonated wellness beverages - the line is ordered, but operations had not begun.
- 10,000 bottles an hour, multiple formats - the planned automated line will handle carbonated and non-carbonated drinks, supported by a retort system for shelf-stable protein shakes.
- Built as a separate legal entity - Olahey Wellness Private Limited was incorporated as a wholly owned subsidiary with a ₹1,00,000 cash investment, giving Influx a dedicated vehicle for a category that sits outside its traditional pill-and-powder CDMO.
- Part of the 2026 innovation wave - functional beverages are listed alongside Quick Snap™ and MMTC as the year’s new-format launches, signalling that the company sees liquids as a growth adjacency rather than a distant experiment.
Group structure and partners
A listed parent with one newly created subsidiary, a UAE outpost in the works, and a tight family-professional leadership.
- Influx Healthtech Ltd is the listed parent, trading on the NSE Emerge platform since June 2025; until February 2026 it had no subsidiaries, when it incorporated Olahey Wellness Private Limited as a wholly owned vehicle for the beverage business.
- The company has identified group entities including Trusan Printpack Private Limited, Nutrapharm India and Influx Foundation, and is progressing plans for a manufacturing presence in the UAE through the Ras Al Khaimah economic zone.